Acute myeloid leukaemia (AML) diagnosis and treatment statistics

Patient Experience

Leukaemia (AML) patients rating their care very good or excellent, 2014, England

'14-day / Two-week wait'

England meets the standard for their country on the percentage of patients first seen by a specialist within two weeks of urgent GP referral for suspected cancer.[1]

'Two-week wait' supports early diagnosis as spotting cancer early is important for improving survival, so it is important that patients with potential cancer symptoms are referred promptly. 

'31-day wait'

Wales meets the standard for their country on the percentage of patients that receive their first cancer treatment within 31 days of a decision to treat, while England does not meet the standard for their country.[1,2]

The speed at which patients receive their first treatment can have a positive outcome on their clinical outcome, so it is important that patients with cancer symptoms are treated promptly.

Cancer waiting times coding and standards are different in each country and so comparisons should not be made between countries, only each country against their own measures.

Acute Leukaemia, Waiting Times, UK countries, 2014-15

    England Wales Scotland Northern Ireland
'14-day wait': seen by specialist following referral Performance 94.1%      
Standard 93%      
Performance against standard Meets standard      
'31-day wait': receipt of first treatment following decision to treat Performance 78.3% 100%    
Standard 96% 98%    
Performance against standard Does not meet standard Meets Standard    

Data not available for '14-day wait' in Wales, Scotland or NI.
Data not available for '31-day wait' in Scotland or NI.
Data too small for '62-day wait' for Wales and not available for England, Scotland or NI.
Last reviewed:

93% of leukaemia (AML) patients rate their care as ‘excellent’ or ‘very good’.[1] Patient experience varies with individual needs and concerns, which are influenced by many aspects of personal background, disease characteristics and the care environment.

81% of patients were given the name of a Clinical Nurse Specialist in charge of their care.[1] Being given the name of a Clinical Nurse Specialist in charge of a patients’ care is the factor most likely to be associated with high patient satisfaction scores.[2]

57% said they saw their GP once or twice before being told they had to go to hospital.[1] How often a patient sees their GP before being referred to hospital varies by cancer type depending on ease of diagnosis.[3]

For leukaemia (AML) the proportion that said they saw their GP once or twice before being told they had to go to hospital is lower than the average for all cancer patients.[1]

Spotting cancer early is important for improving survival so it is important that patients with potential cancer symptoms are referred for tests promptly.

Acute Myeloid Leukaemia (C92.0 C92.4 C92.5 C93.0 C94.0 C94.2), Patient Experience Survey, by Sex, England, 2014

Female Male Persons
Percentage of patients treated for cancer who visited their GP once or twice about the health problem caused by their cancer 53.2% 59.8% 57.1%
Percentage of patients treated for cancer who said they were given the name of a Clinical Nurse Specialist in charge of their care 79.9% 81.5% 80.8%
Percentage of patients treated for cancer who rated their overall care as excellent or very good 92.2% 93.0% 92.6%

Last reviewed:

Cancer Statistics Explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK statistics content for your own work.

Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year]. 

Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK. 

Rate this page:

Currently rated: 1.3 out of 5 based on 3 votes
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page